SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Eramet S.a. (ERMAF) , 前瞻盈利收益率 4.06%.
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 24.6
SharesGrow 综合评分： 47/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
17/100
Debt-to-Equity & liquidity
→ Health
估值概览 — ERMAF
估值倍数
P/E (TTM)0.0
前瞻 P/E24.6
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.58
EV/EBITDA0.0
每股数据
EPS (TTM)$-16.66
前瞻 EPS（预估）$2.25
每股账面价值$0.00
每股营收$96.18
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield4.06%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-6.79 |
$2.95B |
$-179M |
-6.1% |
| 2017 |
$7.03 |
$3.55B |
$203M |
5.7% |
| 2018 |
$1.83 |
$3.75B |
$53M |
1.4% |
| 2019 |
$-6.94 |
$3.67B |
$-184M |
-5% |
| 2020 |
$-25.47 |
$2.79B |
$-675M |
-24.2% |
| 2021 |
$10.39 |
$3.67B |
$298M |
8.1% |
| 2022 |
$25.48 |
$5.01B |
$740M |
14.8% |
| 2023 |
$3.77 |
$3.34B |
$109M |
3.3% |
| 2024 |
$0.49 |
$2.93B |
$14M |
0.5% |
| 2025 |
$-16.66 |
$2.75B |
$-476.82M |
-17.3% |
